Online Only Articles

CD34+ acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness genes and can be targeted by the BCL2 inhibitor venetoclax

Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen
Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen
Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen
Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen
Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen
Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, Groningen
Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands
Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University Nijmegen, Nijmegen, the Netherlands
Department of Hematology, Cancer Research Center Groningen, University Medical Center Groningen, University of Groningen, Groningen
Vol. 105 No. 8 (2020): August, 2020 https://doi.org/10.3324/haematol.2019.229997